Patents
Patents for C07J 7 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms (2,018)
05/2008
05/21/2008EP1265911B1 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents
05/21/2008DE102006054535A1 Progesteronrezeptorantagonisten Progesterone receptor antagonists
05/21/2008CN100389121C Momertasone furoate intermediate 21-hydroxyl preparing process
05/20/2008US7375098 8β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienes
05/14/2008CN101177443A Novel steroid compound and uses thereof
05/13/2008US7371741 Angiogenesis inhibitor
05/06/2008CA2400133C Anaesthetic composition
05/06/2008CA2368370C The use of dienogest in high dosages
04/2008
04/30/2008CN101168555A Preparation of medicine and derivative thereof
04/29/2008US7365218 Process for preparing guggulsterones
04/16/2008CN100381457C 8beta-vinil-11beta-(¿¿mega-substitu¿¼do)alquil-estra-1 ,3,5(10)-trienos
04/15/2008CA2358466C 17.beta.-acyl-17.alpha.-propynyl-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties
04/10/2008US20080085875 Crystalline forms of 11ss-(4-acetylphenyl)-20,20,21,21,21-pentafluoro-17-hydroxy-19-nor-17a-pregna-4,9-dien-3-one
04/09/2008CN100379753C Intermediates for 16 beta -methyl steroids
04/02/2008CN100378118C Pharmaceutical compositions having appetite suppressant activity
04/02/2008CN100378116C High purity composition comprising (7a, 17a,)-17-hydroxy-7-methyl 19-nor-17-prege-5-(10)-en-20-yn-3-one
04/01/2008US7351699 Use of DHEA or precursors or metabolic derivatives thereof as a depigmenting agent
03/2008
03/19/2008CN100375751C Production method of prednisone hydrolysate
03/18/2008US7345037 ipratropium/flutropium/tiotropium derivatives; anticholinergic agent; linked at NO or NO2 group, or group which stimulates endogenous production of NO; beneficial therapeutic effects; asthma, respiratory disorder, cystic fibrosis; synergistic with NO release agent or substrate for nitric oxide synthase
03/05/2008CN100372864C Process for the preparation of 7-alpha-methylsteroids
02/2008
02/13/2008CN100368425C 6,7-oxygenated steroids and uses related thereto
02/05/2008US7326510 Polycarbocyclic derivatives for modification of resist, optical and etch resistance properties
01/2008
01/29/2008US7323454 Etonogestrel undecanoate, decanoate and/or dodecanoate; male and female contraception and hormone replacement therapy; endometriosis, menorrhagia, meno-metrorrhagia, pre-menstrual syndrome and dysmenorrhoea
01/29/2008CA2436540C Pharmaceutical compositions based on anticholinergics and corticosteroids
01/29/2008CA2093808C Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
01/17/2008US20080015173 Estrogen Receptor Modulators
01/16/2008CN100362013C C22 carbanyl steroid compound, synthetic method and its use
01/09/2008CN101100480A New etonogestrel esters
01/08/2008CA2196690C Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function
12/2007
12/27/2007US20070298456 Microbiological process for the production of 7-substitued 11-hydroxy steroids, 7,17-substituted 11-halogen steroids, and uses thereof
12/12/2007CN100354300C Method of obtaining 17alpha-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione
12/12/2007CN100353947C Remedies for retina and choroid diseases containing steroids as the active ingredient
11/2007
11/06/2007US7291610 Estrogenic compounds as anti-mitotic agents
10/2007
10/31/2007EP1437361B1 Method of producing 17beta-(substituted)-3-oxo-delta 1,2-4-azasteroids
10/31/2007CN100345864C Preparation method of steroid medicine for treating respiration channel disease and its intermediate
10/24/2007CN100344362C Fine particles, method and device for preparation thereof, and agent for parenteral injection and method for production thereof
10/10/2007EP1841778A1 Method for preparing medrogestone
10/03/2007EP1244458B1 Weight promoting composition, method, and product
09/2007
09/27/2007US20070225256 Compound
09/26/2007CN101041682A Method for synthesizing prednisolone intermediate 1,4-diolefin-11beta,17alpha-dihydroxide-pregna-3,20- diketone
09/26/2007CN100339486C Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids
08/2007
08/28/2007US7262023 synthesis of steroids by hydroxylation and oxidation with use of microoganisms; biosynthesis
08/23/2007US20070197490 Method for producing 5alpha-pregnane derivative
08/09/2007WO2007089795A1 Article support structure and article attachment kit
08/09/2007CA2641209A1 Article support structure and article attachment kit
08/01/2007EP1019060B1 Androgen synthesis inhibitors
07/2007
07/31/2007CA2223397C Novel nor-pregnanes for inducing hypothalamic effects
07/26/2007WO2007082996A1 Neutral labeling reactants and conjugates derived thereof
07/26/2007WO2007082891A1 Process for the preparation of 11beta-hydr0xy-9beta, 10alpha -steroids employing amycolatopsis mediterranei cells
07/26/2007CA2637731A1 Process for the preparation of 11beta-hydr0xy-9beta, 10alpha -steroids employing amycolatopsis mediterranei cells
07/19/2007US20070167420 Process for preparing a crystalline form of halobetasol propionate
07/17/2007CA2158610C 17-deoxycorticosteroid-21-/o/-carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds
07/11/2007CN1325508C Process for preparing perdnisolone derivatives by one-pot method
07/10/2007CA2283564C Pharmaceutical compositions having appetite suppressant activity
07/05/2007US20070155781 ipratropium/flutropium/tiotropium derivatives; anticholinergic agent; linked at NO or NO2 group, or group which stimulates endogenous production of NO; beneficial therapeutic effects; asthma, respiratory disorder, cystic fibrosis; synergistic with NO release agent or substrate for nitric oxide synthase
07/04/2007CN1990499A Further syntheses of cyproterone acetate
07/03/2007US7238338 Antioxidant, such as ethanol and/or ascorbic acid added to the radiolabeled compound during its preparation and/or storage, allows retention of biological or chemical activity of the radiohalogen-labeled compound such as nucleosides, nucleotides
06/2007
06/14/2007US20070135400 Estradiol derivatives
06/13/2007EP1794176A2 2-substituted estrogen sulphamates for inhibition of steroid sulphatase
06/13/2007EP1444247B1 Tibolone formulations
05/2007
05/30/2007CN1970523A Alpha,beta-unsaturated ketone or arone environment-friendly synthesis method
05/30/2007CN1318442C Dexamethasone sodium phosphate crystal form and its crystallization preparation method
05/24/2007US20070117974 One-pot processes for preparing prednisolone derivatives
05/22/2007CA2276694C New fatty acid derivatives
05/16/2007CN1962680A 20-hydroxy-16 alpha- bromo-steroid compound, synthesis method and its uses
05/10/2007US20070105828 Novel polymorph form M of mifepristone and process for its preparation
05/09/2007CN1314701C New etonogestrel esters
05/08/2007US7214807 Method for the preparation of fluticasone and related 17β-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
05/08/2007US7214672 Preventives/remedies for inflammatory airway diseases
05/02/2007EP1226155B1 18-nor-steroids as selectively active estrogens
04/2007
04/25/2007EP1599233B1 Sterilization of beclomethasone drug particles for pulmonary delivery
04/25/2007CN1951951A Synthesis process of a pregnane compound
04/24/2007US7208485 Crystalline forms of halobetasol propionate
04/24/2007CA2182771C 11-(substituted phenyl)-estra-4,9-diene derivatives
04/24/2007CA2073855C Glycoalkaloids for controlling cellular autophagy
04/04/2007EP1769799A2 Pharmaceutical compositions containing steroidal structures and uses thereof
03/2007
03/21/2007CN1305893C Improved synthesis of cyproterone acetate
03/08/2007US20070055072 Process for preparing guggulsterones and guggulsterol
03/07/2007CN1923842A Preparation method of propionic acid clobetasol
03/07/2007CN1923841A 7 alpha-substituted 11 alpha-hydroxysteroids and its microbiological production method
02/2007
02/27/2007CA2425849C Angiostatic steroids
02/15/2007US20070037782 Therapeutic agent for ageing macular degeneration
02/07/2007CN1908000A Preparation method of 21-hydroxy dexamethasone
02/07/2007CN1907999A Preparation method for 9,11-de-esterification of metllylpredllisolone series products
02/07/2007CN1907998A Refining method of 21-methyl tetraenes as intermediate of dexamethasone
02/07/2007CN1907997A Production method of adding fluorine on triamcinolone
02/01/2007DE19535572B4 Verfahren zur Herstellung von 17 α-Fluor-steroid-ketonen Process for the preparation of 17 α-fluoro-steroid ketones
01/2007
01/23/2007US7166611 Plant extract comprising steroidal glycosides from the genus Trichocaulon or Hoodia produced by solvent extraction
01/18/2007US20070015740 Derivative prodrugs of ethinyl estradiol
01/11/2007US20070010505 Methods of treating disease states using antiangiogenic agents
01/10/2007CN1894271A Glycosylated steroid derivatives with anti-migratory activity
01/09/2007US7160920 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
01/03/2007CN1887897A Chemical synthesis of free megestrol
01/02/2007CA2168850C Estrogenic compounds as anti-mitotic agents
12/2006
12/27/2006EP1513861B1 New etonogestrel esters
12/27/2006CN1884297A Method for synthesizing 16-dehydropregndiketonic alcohol acetic ester and its analogs
12/19/2006CA2365083C Process for producing 4,4-dimethyl-3.beta.-hydrocypregna-8,14-diene-21-carboxylic acid esters and intermediate products obtained by said process
12/14/2006DE102005009194B4 Verfahren zur Herstellung von polymorph stabilem Triamcinolonacetonid A process for producing polymorphic stable triamcinolone acetonide
12/07/2006US20060276443 21-substituted progesterone derivatives as new antiprogestational agents
11/2006
11/22/2006EP1572715B1 Steroid compounds with anti-tumor activity
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 21